The pharmaceutical giants look remarkably similar to the IBM of the late 80′s and early 90′s.

For those of us who remember the IBM of that era, this is bad news.

They can continue the path of the railroad industry early in the 20th century. Alternatively, they can look to the path IBM took when its future prospects were grim.

Remarkably, IBM demonstrated how it’s possible for a large company to shift from a product-centric culture to a customer and service centered company.

The writing is on the wall for pharma companies: they will succeed or fail based not on how many drugs they sell, but on how well their offerings improve health outcomes.

See on www.forbes.com